Jushi Holdings (JUSHF) EPS (Diluted) Growth (1y) (2022 - 2026)
Jushi Holdings (JUSHF) EPS (Diluted) Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -304.28% |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 1.28% |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -15.70% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 13.47% |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 30.20% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 385.28% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 41.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.46% |
| Mar 31, 2026 | -14.90% |
| Dec 31, 2025 | -24.74% |
| Sep 30, 2025 | -47.89% |
| Jun 30, 2025 | -536.09% |
| Mar 31, 2025 | 7.33% |
| Dec 31, 2024 | 30.89% |
| Sep 30, 2024 | 22.35% |
| Jun 30, 2024 | 86.22% |
| Mar 31, 2024 | -46.73% |
| Dec 31, 2023 | 86.51% |
| Sep 30, 2023 | 60.74% |
| Jun 30, 2023 | -222.86% |
| Mar 31, 2023 | 32.56% |
| Dec 31, 2022 | -2,324.09% |
| Sep 30, 2022 | -235.20% |
| Jun 30, 2022 | 337.36% |